|
India News Releases
|
(India.CityRegions.Com, January 30, 2018 ) Publisher's clinical trial report, "Bladder Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Publisher Clinical Trial Reports are generated using Publisher's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Request a Sample Report@ http://www.reportsweb.com/inquiry&RW00011454608/sample
Scope: -The report provides a snapshot of the global clinical trials landscape -Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status -The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company -The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment -The Report provides enrollment trends for the past five years -Report provides latest news for the past three months
Reasons to buy: -Assists in formulating key business strategies with regards to investment -Helps in identifying prominent locations for conducting clinical trials which saves time and cost -Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities -Supports understanding of trials count and enrollment trends by country in global therapeutics market -Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials -Facilitates clinical trial assessment of the indication on a global, regional and country level
Inquire before Buying@ http://www.reportsweb.com/inquiry&RW00011454608/buying
Companies Mentioned: Merck & Co Inc F. Hoffmann-La Roche Ltd AstraZeneca Plc Bristol-Myers Squibb Co Pfizer Inc Sarah Cannon Research Institute LLC GlaxoSmithKline Plc Eli Lilly and Co Novartis AG Celgene Corp
Table of Contents: Table of Contents 2 List of Tables 4 List of Figures 4 Report Guidance 5 Publisher Clinical Trials Report Coverage 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Clinical Trials by G7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials 28 Prominent Drugs 29 Latest Clinical Trials News on Bladder Cancer 30 Dec 08, 2017: Researchers Discover Resistance Mechanism To Checkpoint Inhibitors And How To Reverse It 30 Dec 08, 2017: Landmark Blue Light Cystoscopy with Cysview study is published in the Journal of Urology 30 Nov 15, 2017: BioCanCell Announces Updated Results from the Phase 2 Clinical Trial of BC-819 and BCG in Patients with Bladder Cancer 31 Nov 11, 2017: First Data for NKTR-214 in Combination with OPDIVO (nivolumab) for Patients with Stage IV Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancers, Including Patients with PD-L1 Negative Status, Revealed at SITC 2017 31 Nov 10, 2017: Five Prime Therapeutics Presents Poster on FGFR2b Expression and Immune Signature in Urothelial Cancer at the Society for Immunotherapy of Cancer 32nd Annual Meeting 33 Oct 30, 2017: Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy 33 Oct 23, 2017: BLC With Cysview/Hexvix Real World Data Presented at the Société Internationale D'urologie 2017 Annual Meeting 34 Oct 02, 2017: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343 34 Sep 12, 2017: Oncology Research: New Opportunities for Menarini and OBT 34 Clinical Trial Profile Snapshots 36 Appendix 606
For more information about this report@ http://www.reportsweb.com/bladder-cancer-global-clinical-trials-review-h2-2017
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|